SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-174184
Filing Date
2018-05-25
Accepted
2018-05-25 06:12:32
Documents
3
Period of Report
2018-05-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d577091d8k.htm 8-K 14893
2 EX-99.1 d577091dex991.htm EX-99.1 23377
3 GRAPHIC g577091g0525025555786.jpg GRAPHIC 2814
  Complete submission text file 0001193125-18-174184.txt   43376
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30929 | Film No.: 18859596
SIC: 2834 Pharmaceutical Preparations